[Evolution of endocrine therapy for prostate cancer].
Igawa
T
T
Department of Urology, Nagasaki University School of Medicine.
Saito
Y
Y
D000726:Androgen Antagonists / Q000627:therapeutic use; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D017273:Goserelin / Q000627:therapeutic use; D006801:Humans; D016729:Leuprolide / Q000627:therapeutic use; D008297:Male; D009376:Neoplasms, Hormone-Dependent / Q000628:therapy*; D011471:Prostatic Neoplasms / Q000628:therapy*
D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal; D017273:Goserelin; D016729:Leuprolide